Oncology research experts from across the country have come together to establish a new collaboration to accelerate cancer research, translating scientific discoveries into tangible benefits for patients.

A simple injection of a common antiseptic could boost the cancer-killing effect of radiotherapy for breast cancer and other cancers, an early clinical trial has shown.

Giving people with bladder cancer fewer but larger doses of radiation reduces the risk of their disease returning and should be adopted as the new standard of care, according to a new study, published in The Lancet Oncology today.

A new experimental drug could offer a promising approach to treating men with advanced prostate cancer which does not respond to existing treatments, or develops resistance to them, researchers report.

The NIHR Biomedical Research Centre at The Royal Marsden and the ICR (BRC) has a proud tradition of working in partnership with patients and the public to ensure our services and research function best for the communities we serve.

Black men are more likely than their White or Asian counterparts to have a range of genetic changes that increase their risk of developing prostate cancer, a major new study reports.

Grainne Brady and Lauren Leigh-Doyle, members of the Speech and Language Therapy (SLT) team at The Royal Marsden NHS Foundation Trust have both been awarded prestigious National Institute of Health Research (NIHR) fellowships to support them on their trajectory to becoming future leaders in NIHR research.

Patients with specific types of blood cancer (Non-Hodgkin lymphoma) could receive an improved and more accurate diagnosis through new genetic testing.

A blood test to watch breast cancer’s ‘molecular clock’ could help track the growth of multiple tumours around the body and monitor how they are responding to treatment, new research suggests.

A simple and inexpensive blood test could pick out patients with stomach or oesophageal cancer who are likely to benefit from targeted treatment, a new study shows.